Riskpilot← Back to searchSign inGet full accessTandläkarbröderna AB
ABActiveOrg 5591366009Västra Hamngatan 19Dental practice care activities · NACE 8623Est. 20175 employees
Revenue 2024
SEK 6,2M
+28% vs 2023
EBITDA margin
8.4%
+327% vs 2023
Equity ratio
25.8%
Financial strength
Net profit 2024
SEK 363K
+1034% vs 2023
| Revenue | SEK 6,2M | +28% |
| EBITDA | SEK 521K | +327% |
| Net profit | SEK 363K | +1034% |
| Total assets | SEK 3,3M | +25% |
| Equity | SEK 855K | +74% |
| Employees | 5 | — |
Legal name
Tandläkarbröderna AB
Org number
5591366009
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
1 december 2017
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva utbildning och konsultverksamhet inom odontologi, förvalta fast egendom och värdepapper samt idka därmed förenlig verksamhet.
Address
Västra Hamngatan 19
Email
jackhilon@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 788 | 4 062 | 3 847 | 4 842 | 6 181 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 623 | 269 | 1 119 | 122 | 521 |
| Depreciation & amort. | −320 | −370 | −396 | −176 | −211 |
| EBIT | 1 303 | −101 | 723 | −54 | 310 |
| Net financials | −11 | −2 | — | 3 | 9 |
| Profit before tax | 984 | 4 | 362 | 48 | 470 |
| Tax | −214 | −4 | −76 | −16 | −107 |
| Net profit | 770 | 0 | 286 | 32 | 363 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 713 | 3 347 | 2 274 | 2 650 | 3 316 |
| Equity | 1 673 | 1 673 | 460 | 491 | 855 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 841 | 582 | 362 | 806 | 1 259 |
| Total debt | 841 | 582 | 362 | 806 | 1 259 |
EBITDA margin
8.4%
This company
15.8%
Market median
-47% vs market
20202024
Equity ratio
25.8%
This company
38.2%
Market median
-32% vs market
20202024
Return on equity
42.5%
This company
18.4%
Market median
+131% vs market
20202024
Net profit margin
5.9%
This company
8.1%
Market median
-27% vs market
20202024
Asset turnover
1.86×
This company
1.12×
Market median
+66% vs market
20202024
Debt / equity
2.88×
This company
0.62×
Market median
-365% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
BL | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tandläkarbröderna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jack Hilon | Chief Executive Officer | 0 companies |
| Björn Lars Arnold Elken | Audit | 0 companies |
| Fouad Hilon | Deputy Board Member | 0 companies |